**Question:** The hypersensitivity reaction involved in the hyper-acute rejection of renal transplant is:

A. Antibody-mediated rejection
B. T cell-mediated rejection
C. Cytotoxic T lymphocyte-mediated rejection
D. Complement-mediated rejection

**Core Concept:**

Hyper-acute rejection is a severe form of renal transplant rejection that occurs within minutes to hours after organ transplantation. This type of rejection is characterized by rapid destruction of the transplanted organ, primarily due to the activation of the complement system, which is part of the immune response. The complement system is a group of proteins that play a crucial role in the immune response, including inflammation, phagocytosis, and the formation of membrane attack complex (MAC), which leads to cell lysis.

**Why the Correct Answer is Right:**

D. Complement-mediated rejection (Option D) is the correct answer because it explains the underlying mechanism of hyper-acute rejection. The complement system is activated in hyper-acute rejection, leading to the formation of the membrane attack complex (MAC) on the surface of transplanted renal cells. This results in cell lysis and death of the transplanted kidney, causing the severe rejection observed clinically.

**Why Each Wrong Option is Incorrect:**

A. Antibody-mediated rejection (Option A) and B. T cell-mediated rejection (Option B) are related to acute cellular rejection, which occurs within days to weeks after transplantation. Hyper-acute rejection, on the other hand, occurs much earlier, making these options irrelevant to the scenario.

C. Cytotoxic T lymphocyte-mediated rejection (Option C) is involved in the acute cellular rejection, not hyper-acute rejection. Cytotoxic T lymphocytes play a role in the destruction of transplanted cells by releasing cytotoxic molecules like perforin and granzymes, whereas hyper-acute rejection is primarily driven by complement activation.

**Clinical Pearl:**

Hyper-acute rejection is a severe complication in renal transplantation and emphasizes the importance of proper immunosuppressive therapy and donor-recipient compatibility to minimize such events and ensure long-term graft survival. Understanding the mechanisms of hyper-acute rejection can help clinicians tailor their therapeutic approaches to reduce the risk of this critical complication.